- Home
- AMLX vs AC Comparison
AMLX vs AC Comparison
Compare AMLX & AC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- AC
- Stock Information
- Founded
- AMLX 2014
- AC 1976
- Country
- AMLX United States
- AC United States
- Employees
- AMLX N/A
- AC 25
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- AC Investment Bankers/Brokers/Service
- Sector
- AMLX Health Care
- AC Finance
- Exchange
- AMLX Nasdaq
- AC Nasdaq
- Market Cap
- AMLX 749.9M
- AC 773.3M
- IPO Year
- AMLX 2022
- AC N/A
- Fundamental
- Price
- AMLX $8.00
- AC $36.72
- Analyst Decision
- AMLX Strong Buy
- AC
- Analyst Count
- AMLX 7
- AC 0
- Target Price
- AMLX $12.00
- AC N/A
- AVG Volume (30 Days)
- AMLX 1.0M
- AC 4.7K
- Earning Date
- AMLX 08-07-2025
- AC 08-06-2025
- Dividend Yield
- AMLX N/A
- AC 0.55%
- EPS Growth
- AMLX N/A
- AC 64.87
- EPS
- AMLX N/A
- AC 2.54
- Revenue
- AMLX N/A
- AC $11,905,000.00
- Revenue This Year
- AMLX N/A
- AC N/A
- Revenue Next Year
- AMLX N/A
- AC N/A
- P/E Ratio
- AMLX N/A
- AC $14.45
- Revenue Growth
- AMLX N/A
- AC N/A
- 52 Week Low
- AMLX $2.05
- AC $29.18
- 52 Week High
- AMLX $8.72
- AC $43.85
- Technical
- Relative Strength Index (RSI)
- AMLX 53.91
- AC 46.70
- Support Level
- AMLX $7.48
- AC $36.56
- Resistance Level
- AMLX $8.49
- AC $37.01
- Average True Range (ATR)
- AMLX 0.40
- AC 0.59
- MACD
- AMLX -0.06
- AC 0.00
- Stochastic Oscillator
- AMLX 51.49
- AC 76.11
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About AC Associated Capital Group Inc.
Associated Capital Group Inc is a diversified financial services company. It operates in the business of alternative investment management, institutional research services, and cash and other assets through subsidiaries. The activities of its subsidiaries comprise publishing daily research notes and full reports using private market value with a catalyst methodology and also products and customized solutions utilizing private market value with catalyst method of investing.